182 related articles for article (PubMed ID: 28123152)
1. The Anti-dementia Effects of Donepezil Involve miR-206-3p in the Hippocampus and Cortex.
Wang CN; Wang YJ; Wang H; Song L; Chen Y; Wang JL; Ye Y; Jiang B
Biol Pharm Bull; 2017 Apr; 40(4):465-472. PubMed ID: 28123152
[TBL] [Abstract][Full Text] [Related]
2. Donepezil improves learning and memory deficits in APP/PS1 mice by inhibition of microglial activation.
Guo HB; Cheng YF; Wu JG; Wang CM; Wang HT; Zhang C; Qiu ZK; Xu JP
Neuroscience; 2015 Apr; 290():530-42. PubMed ID: 25662507
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-574 is involved in cognitive impairment in 5-month-old APP/PS1 mice through regulation of neuritin.
Li F; Wei G; Bai Y; Li Y; Huang F; Lin J; Hou Q; Deng R; Zhou JH; Zhang SX; Chen DF
Brain Res; 2015 Nov; 1627():177-88. PubMed ID: 26423933
[TBL] [Abstract][Full Text] [Related]
4. Protocatechuic acid improves cognitive deficits and attenuates amyloid deposits, inflammatory response in aged AβPP/PS1 double transgenic mice.
Song Y; Cui T; Xie N; Zhang X; Qian Z; Liu J
Int Immunopharmacol; 2014 May; 20(1):276-81. PubMed ID: 24667368
[TBL] [Abstract][Full Text] [Related]
5. Folic acid deficiency enhances abeta accumulation in APP/PS1 mice brain and decreases amyloid-associated miRNAs expression.
Liu H; Tian T; Qin S; Li W; Zhang X; Wang X; Gao Y; Huang G
J Nutr Biochem; 2015 Dec; 26(12):1502-8. PubMed ID: 26345540
[TBL] [Abstract][Full Text] [Related]
6. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine.
Nagakura A; Shitaka Y; Yarimizu J; Matsuoka N
Eur J Pharmacol; 2013 Mar; 703(1-3):53-61. PubMed ID: 23276665
[TBL] [Abstract][Full Text] [Related]
7. Donepezil attenuates Aβ-associated mitochondrial dysfunction and reduces mitochondrial Aβ accumulation in vivo and in vitro.
Ye CY; Lei Y; Tang XC; Zhang HY
Neuropharmacology; 2015 Aug; 95():29-36. PubMed ID: 25744714
[TBL] [Abstract][Full Text] [Related]
8. Identification of potential therapeutic and diagnostic characteristics of Alzheimer disease by targeting the miR-132-3p/FOXO3a-PPM1F axis in APP/PS1 mice.
Fu X; Liu J; Xie J; Chen G; Zhang H; Meng F; Wu M; Li Q; Liu Y; Wang W; Dai J; Wang D; Zhao D; Li C; Wang X
Brain Res; 2022 Sep; 1790():147983. PubMed ID: 35709892
[TBL] [Abstract][Full Text] [Related]
9. Amalaki Rasayana improved memory and neuronal metabolic activity in AbPP-PS1 mouse model of Alzheimer's disease.
Tiwari V; Saba K; Veeraiah P; Jose J; Lakhotia SC; Patel AB
J Biosci; 2017 Sep; 42(3):363-371. PubMed ID: 29358550
[TBL] [Abstract][Full Text] [Related]
10. miR-124 regulates cerebromicrovascular function in APP/PS1 transgenic mice via C1ql3.
Li AD; Tong L; Xu N; Ye Y; Nie PY; Wang ZY; Ji LL
Brain Res Bull; 2019 Nov; 153():214-222. PubMed ID: 31499089
[TBL] [Abstract][Full Text] [Related]
11. Icariin, a phosphodiesterase-5 inhibitor, improves learning and memory in APP/PS1 transgenic mice by stimulation of NO/cGMP signalling.
Jin F; Gong QH; Xu YS; Wang LN; Jin H; Li F; Li LS; Ma YM; Shi JS
Int J Neuropsychopharmacol; 2014 Jun; 17(6):871-81. PubMed ID: 24513083
[TBL] [Abstract][Full Text] [Related]
12. Self-assembling nanofibers alter the processing of amyloid precursor protein in a transgenic mouse model of Alzheimer's disease.
Yang H; Yang H; Xie Z; Wang P; Bi J
Neurol Res; 2015 Jan; 37(1):84-91. PubMed ID: 25005263
[TBL] [Abstract][Full Text] [Related]
13. In vivo 1H-magnetic resonance spectroscopy can detect metabolic changes in APP/PS1 mice after donepezil treatment.
Westman E; Spenger C; Oberg J; Reyer H; Pahnke J; Wahlund LO
BMC Neurosci; 2009 Apr; 10():33. PubMed ID: 19351388
[TBL] [Abstract][Full Text] [Related]
14. Gender difference in valproic acid-induced neuroprotective effects on APP/PS1 double transgenic mice modeling Alzheimer's disease.
Long Z; Zeng Q; Wang K; Sharma A; He G
Acta Biochim Biophys Sin (Shanghai); 2016 Oct; 48(10):930-938. PubMed ID: 27614317
[TBL] [Abstract][Full Text] [Related]
15. Osthole Upregulates BDNF to Enhance Adult Hippocampal Neurogenesis in APP/PS1 Transgenic Mice.
Liu H; Xue X; Shi H; Qi L; Gong D
Biol Pharm Bull; 2015; 38(10):1439-49. PubMed ID: 26424009
[TBL] [Abstract][Full Text] [Related]
16. miR-200a-3p promotes b-Amyloid-induced neuronal apoptosis through down-regulation of SIRT1 in Alzheimer's disease.
Zhang QS; Liu W; Lu GX
J Biosci; 2017 Sep; 42(3):397-404. PubMed ID: 29358553
[TBL] [Abstract][Full Text] [Related]
17. Identification of Circulating miR-125b as a Potential Biomarker of Alzheimer's Disease in APP/PS1 Transgenic Mouse.
Hong H; Li Y; Su B
J Alzheimers Dis; 2017; 59(4):1449-1458. PubMed ID: 28731435
[TBL] [Abstract][Full Text] [Related]
18. Effects of donepezil on amyloid-beta and synapse density in the Tg2576 mouse model of Alzheimer's disease.
Dong H; Yuede CM; Coughlan CA; Murphy KM; Csernansky JG
Brain Res; 2009 Dec; 1303():169-78. PubMed ID: 19799879
[TBL] [Abstract][Full Text] [Related]
19. Expression of APP, BACE1, AChE and ChAT in an AD model in rats and the effect of donepezil hydrochloride treatment.
Li Q; Chen M; Liu H; Yang L; Yang G
Mol Med Rep; 2012 Dec; 6(6):1450-4. PubMed ID: 23023803
[TBL] [Abstract][Full Text] [Related]
20. Safflower Yellow Improves Synaptic Plasticity in APP/PS1 Mice by Regulating Microglia Activation Phenotypes and BDNF/TrkB/ERK Signaling Pathway.
Pang J; Hou J; Zhou Z; Ren M; Mo Y; Yang G; Qu Z; Hu Y
Neuromolecular Med; 2020 Sep; 22(3):341-358. PubMed ID: 32048142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
